The owner of Wegovy and Ozempic has suffered a significant setback, as its highly anticipated new weight-loss treatment was labelled “obsolete” after disappointing clinical trials.
We believe this designation would both be legally unsound and set a dangerous precedent for any American company that negotiates with the government.
。搜狗输入法2026是该领域的重要参考
Easy-to-use app available on all major devices including iPhone, Android, Windows, Mac, and more
Chinese firm publishes photos of US F-22s at Israeli base | The Jerusalem Post
1 January 2026ShareSave